Sample Testing. 9.1. On completion of the harvest, and in any event no later than 30th April of the year of harvest, the Grower will supply a harvest sample of each line of Crop to the Purchaser.
Sample Testing. (i) For the PCV Program, Moderna shall provide samples of biological material collected from subjects participating in a Clinical Study performed under the POC Plan for the PCV Program, including blood and/or tissue samples, to Merck as specified in the applicable protocol or as agreed to by the POC Committee.
Sample Testing. 8.1 The Grower shall during the harvest of the Crop obtain a 2 kilogram sample which is truly representative of the whole of the Crop (‘the Sample’).
Sample Testing. 3.8.1. Collaborator shall provide Samples to MSD as specified in the Protocol and as agreed to by the Joint Development Committee. Each Party shall use the Samples only for Sample Testing in accordance with the Sample Testing Schedule and the Protocol. [***].
Sample Testing. 3.7.1. Company shall provide Samples to Merck as specified in the Protocol or as agreed to by the Joint Development Committee. Each Party shall (a) use the Samples only for the Sample Testing and (b) conduct the Sample Testing solely in accordance with the Data Sharing and Sample Testing Schedule and the Protocol.
Sample Testing. Seller may at its sole option, but is not obligated to, perform adequate testing to assure that shipped Products meet Buyer's sample testing criteria established in Attachment D. Notwithstanding the foregoing, prior to Seller initiating the volume manufacture of Products, Buyer shall have the right at its sole option, but is not obligated to, conduct sample testing of incoming Products and to reject lots that fail to meet the applicable product specifications and quality levels set forth in this Agreement and Attachments hereto (including the quality levels set forth in Attachment D), and/or US regulatory requirements and US law. Buyer shall have the right to conduct such testing either at Seller's manufacturing facility ("on-site testing") or Buyer's facility ("off-site testing"). Neither Buyer's waiver of its right to conduct sample testing nor Buyer's conducting sample testing in any way other than as set forth in Attachment D shall derogate from or otherwise affect in any way Buyer's other rights or remedies under this Agreement, including by illustration and not limitation its rights and remedies under sections 13, 14, or 17.
Sample Testing. 3.7.1. FLX shall provide Samples to Merck as specified in the Protocol or as agreed to by the Joint Development Committee. Each Party shall (a) use the Samples only for the Sample Testing and (b) conduct the Sample Testing solely in accordance with the Data Sharing and Sample Testing Schedule and the Protocol.
Sample Testing. Sample testing of products serves to provide evidence before the start of the series that required qual- ity control standards as designated in the drawings and specifications have been achieved. Sample testing is carried out in accordance with PPAP or VDA 2 / PPF. The procedure and submission level to be applied will be agreed with the supplier.
Sample Testing. 3.7.1 Rexahn shall provide Samples to Merck as specified in the Protocol or as agreed to by the Joint Development Committee. Each Party shall (a) use the Samples only for the Sample Testing, and (b) conduct the Sample Testing assigned to such Party on the Data Sharing and Sample Testing Schedule solely in accordance with the Data Sharing and Sample Testing Schedule and the Protocol. All Sample Testing Results shall be [***] under the Sample Testing Results. If such assignment cannot or does not occur, including in circumstances where such assignment is precluded by Applicable Law, the Party with the obligation to assign hereby grants the other Party [***]. Excluded Merck Results shall be solely owned by Merck. [***] INDICATES MATERIAL THAT WAS OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT WAS REQUESTED. ALL SUCH OMITTED MATERIAL WAS FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
Sample Testing. Within seven (7) days after Cardinal Health's completion of Processing of each Batch, Cardinal Health shall provide Client or its designee with a sample of the Product ("SAMPLE") and Cardinal Health's Certificate of Analysis for such Batch. No later than twenty one (21) days after receipt of the Sample, Client or its designee shall notify Cardinal Health whether or not the Sample conforms to the warranty set forth in Section 10.1 of this Agreement. Upon receipt of notice from Client that a Batch meets the warranty in Section 10.1, or upon failure of Client to respond by the end of such twenty one (21)-day period, Cardinal Health will invoice Client for such Batch. For avoidance of doubt, nothing in this Section 5.1 shall preclude Client from retesting samples of delivered Batches, at its own expense, for the purpose of determining whether any Batch meets the warranty in Section 10.1.
